Brief: Allergy Therapeutics Targeting HKEX Listing Effective First Half Of 2026
06/11/2025 08:16
Nov 6 (Reuters) - Allergy Therapeutics PLC AGY.L: ALLERGY THERAPEUTICS - COMPANY TO EVALUATE DUAL LISTING ON HKEX ALLERGY THERAPEUTICS PLC - TARGETING HKEX LISTING EFFECTIVE FIRST HALF OF 2026 Source text: ID:nRSF4682Ga Further company coverage: AGY.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman